IperionX arrives at its June 16 earnings event with short sellers pulling back even as the stock recovers — a shift in tone from the positioning picture that defined the previous preview ten days ago.
Short interest has retreated meaningfully over the past week. Bears have trimmed positions by roughly 4% in seven days, bringing short interest down to 8.6% of the free float — still a material level for a diversified metals name, but moving in the wrong direction for the bear case. Days to cover remain high at 17.7, reflecting how thinly traded the stock is relative to the short position. The borrow market itself is well-supplied: availability has widened sharply to 285%, up 36% week-on-week, meaning there is now nearly three times as much stock available to borrow as is currently borrowed. Borrowing costs have edged down slightly on the week at 3.3%, though they remain about a third higher than a month ago. The ORTEX short score has drifted lower — from 75.5 ten days ago to 72.5 now — consistent with that gradual unwind. The stock jumped 6.3% on Monday to A$5.44, its best single-session move in weeks, and is essentially flat on the week.
The bull case rests on two pillars that have not changed since the June 6 preview. Executive Chairman Todd Hannigan and CEO Taso Arima each made open-market purchases in late March and late April at prices between A$3.20 and A$4.50, committing a combined ~A$2.3 million of personal capital near the lows. Those positions are now materially in the money. The 90-day net insider position across the company remains firmly in buying territory at 1.43 million shares. Van Eck, the second-largest holder, added over 15 million shares as recently as May 31 — a 51% increase in its position — making it a conviction-sized bet from a firm that tracks critical minerals closely. A recent note flags a rare earth separation breakthrough at IperionX's processing facility, moving the company closer to production phase in the context of Western governments' drive for non-Chinese supply chains. The three buy-rated analysts on the stock carry no recent target changes in the data, so the consensus view has not shifted ahead of today.
The bear case is harder to dismiss entirely at 8.6% of float. A history of sharp downside reactions around events — including a 26% single-day drop and a 50% five-day loss following the March 12 event — means the short book is not irrational, even if it is shrinking. The previous print on April 27 produced an 8.3% gain and a 14.5% five-day move, showing the reaction profile is highly asymmetric and event-dependent. Peers are broadly moving in the same direction today: SBM gained 6.4%, AMI 10.3%, and A1M 10.5% on the session, suggesting sector tailwinds rather than company-specific momentum driving the Monday bounce.
Today's print is therefore less a test of whether the critical minerals thesis is intact and more a question of whether IperionX can show commercial progress — permitting, offtake, or capital allocation — that justifies the distance between the current price and the insider-implied value embedded in those late-April buys.
See the live data behind this article on ORTEX.
Open IPX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
